Impact of the addition of rituximab in adults with newly diagnosed Philadelphia chromosome-positive acute lymphoblastic leukemia
Leuk Lymphoma
.
2024 Dec 1:1-4.
doi: 10.1080/10428194.2024.2432582.
Online ahead of print.
Authors
Fausto Alfredo Rios-Olais
1
,
Sergio Rodriguez-Rodriguez
1
,
Analy Mora-Cañas
2
,
Christian Omar Ramos-Peñafiel
3
,
Victor Itaí Urbalejo-Ceniceros
4
,
Yadith Karina Lopez-Garcia
5
,
Andres Gomez-De Leon
5
,
Nancy Delgado-Lopez
6
,
Mistral Castellanos-Mares
4
,
Patricia Carolina Figueroa-Hernandez
4
,
Roberta Demichelis-Gomez
1
Affiliations
1
Hematology and Oncology Department, Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Mexico City, Mexico.
2
Internal Medicine Department, Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Mexico City, Mexico.
3
Hematology Department, Hospital General de México, Mexico City, Mexico.
4
Hematology Department, Instituto Nacional de Cancerología, Mexico City, Mexico.
5
Universidad Autónoma de Nuevo León, Facultad de Medicina y Hospital Universitario Dr. Jose Eleuterio Gonzalez, Monterrey, Mexico.
6
Hospital de Especialidades, Centro Médico Nacional Siglo XXI, Mexico City, Mexico.
PMID:
39616625
DOI:
10.1080/10428194.2024.2432582
No abstract available